Yehia Hashad Bausch & Lomb Corp (BLCO) insider trading activity

Yehia Hashad is EVP of R&D and CMO of Bausch & Lomb Corp. Currently has a direct ownership of 134,454 shares of BLCO, which is worth approximately $1.86 Million. The most recent transaction as insider was on Aug 05, 2025, when has been sold 17,715 shares (Common Shares, no par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 134K

12.44% 3M change

35.22% 12M change

Total Value Held $1.86 Million

Yehia Hashad Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 05 2025	BUY Grant, award, or other acquisition	-	17,715 Added 11.64%	134,454 Common Shares, no par ...
Jul 25 2025	SELL Payment of exercise price or tax liability	$40,683 $14.32 p/Share	2,841 Reduced 2.38%	116,739 Common Shares, no par ...
Feb 26 2025	BUY Grant, award, or other acquisition	-	25,225 Added 17.42%	119,580 Common Shares, no par ...
Dec 23 2024	SELL Payment of exercise price or tax liability	$90,487 $17.83 p/Share	5,075 Reduced 5.1%	94,355 Common Shares, no par ...
Jul 25 2024	SELL Payment of exercise price or tax liability	$44,120 $15.53 p/Share	2,841 Reduced 2.78%	99,430 Common Shares, no par ...
Mar 01 2024	SELL Payment of exercise price or tax liability	$35,295 $16.47 p/Share	2,143 Reduced 2.05%	102,271 Common Shares, no par ...
Feb 28 2024	BUY Grant, award, or other acquisition	-	20,973 Added 16.73%	104,414 Common Shares, no par ...
Jul 25 2023	SELL Payment of exercise price or tax liability	$79,200 $19.82 p/Share	3,996 Reduced 4.57%	83,441 Common Shares, no par ...
Mar 01 2023	BUY Grant, award, or other acquisition	-	17,715 Added 16.85%	87,437 Common Shares, no par ...
Jul 25 2022	BUY Grant, award, or other acquisition	-	35,000 Added 33.42%	69,722 Common Shares, no par ...
May 05 2022	BUY Grant, award, or other acquisition	-	34,722 Added 50.0%	34,722 Common Shares, no par ...

Also insider at

AGTC

APPLIED GENETIC TECHNOLOGIES CORP Healthcare

Director

UBX

Unity Biotechnology, Inc. Healthcare

Yehia Hashad

EVP of R&D and CMO

Vaughan, A6

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLCO shares.

Notify only if

Value

Insider Trading

Get notified when an Bausch & Lomb Corp insider buys or sells BLCO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Bausch & Lomb Corp

Track Activities on BLCO

Account